Correlation Between Sartorius Stedim and Affluent Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Affluent Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Affluent Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Affluent Medical SAS, you can compare the effects of market volatilities on Sartorius Stedim and Affluent Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Affluent Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Affluent Medical.

Diversification Opportunities for Sartorius Stedim and Affluent Medical

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Sartorius and Affluent is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Affluent Medical SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affluent Medical SAS and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Affluent Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affluent Medical SAS has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Affluent Medical go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Affluent Medical

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.65 times more return on investment than Affluent Medical. However, Sartorius Stedim Biotech is 1.55 times less risky than Affluent Medical. It trades about -0.1 of its potential returns per unit of risk. Affluent Medical SAS is currently generating about -0.16 per unit of risk. If you would invest  19,075  in Sartorius Stedim Biotech on August 29, 2024 and sell it today you would lose (1,165) from holding Sartorius Stedim Biotech or give up 6.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Affluent Medical SAS

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Affluent Medical SAS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Affluent Medical SAS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Sartorius Stedim and Affluent Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Affluent Medical

The main advantage of trading using opposite Sartorius Stedim and Affluent Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Affluent Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affluent Medical will offset losses from the drop in Affluent Medical's long position.
The idea behind Sartorius Stedim Biotech and Affluent Medical SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stocks Directory
Find actively traded stocks across global markets